查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1631127

活性藥物成分市場規模、佔有率、趨勢分析報告：按合成類型、按製造商、按類型、按應用、按地區、按細分市場、預測，2025-2030 年

Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type of Synthesis, By Type of Manufacturer, By Type, By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 189 Pages | 商品交期: 2-10個工作天內

價格

活性藥物成分市場的成長與趨勢

根據Grand View Research, Inc.的新報告，到2030年全球活性藥物成分市場規模預計將達到3,594.5億美元。

預計 2025 年至 2030 年間市場複合年成長率為 5.85%。這一市場受到生物製藥領域的成長、活性藥物成分 (API) 製造的進步以及老年人口的成長所推動。

專屬式API 領域的成長將受到那些投資應對挑戰和開發內部 API 生產新化學方法的公司所推動。這有助於降低成本和污染風險。人工智慧和蛋白質合成有望提供對過程的更大控制並促進更快的發展。

心血管疾病等慢性病和生活方式驅動的疾病發生率不斷上升，推動了對 API 的需求。例如，根據2020年美國藥劑師學會的數據，47%的成年人至少有一個心血管疾病的危險因子。心血管疾病是全球主要的公共衛生負擔之一，推動了該領域對活性藥物成分的廣泛研究和發展。

活性藥物成分市場受到了新冠肺炎疫情的正面影響，各國和主要企業生產大量成分以滿足新冠肺炎治療的需求。由於疫情的影響，製藥公司已經轉變策略，將重點放在更大的患者群體。例如，為了治療冠狀病毒，美國已要求從印度進口羥氯奎。該病毒也影響了加拿大的藥品供應系統，可能會為患者帶來併發症。學名藥重要性的日益提升、生物製藥消費量的不斷增加以及製藥製造研發活動的不斷擴大是市場成長的主要驅動力。然而，市場擴張可能會因一些國家不利的藥品定價規定和高昂的製造成本而受到阻礙。

由於地緣政治因素，印度等新興國家比中國等 API 市場主導國家更受市場青睞。此外，印度擁有高品質的原料和產品、大量的勞動力、龐大的分銷網路以及政府透過「印度製造」計劃提供的補貼。

兩家公司正在合作開發新治療方法，以滿足尚未滿足的醫療需求。這使得公司能夠利用其資源來支援產品開發並加強其供應鏈。 2021 年 11 月，默克宣布收購 Acceleron Pharma。此次收購預計將有助於擴大默克公司的心血管產品組合和產品線。

活性藥物成分市場報告重點

  • 由於研發活動的活性化和政府積極推動開發新藥，創新 API 預計將在 2024 年佔據 62.0% 的最大佔有率。
  • 專屬式API 部門在 2024 年佔最大佔有率，為 51.03%。
  • 由於原料的可用性高且這些分子的合成方案簡單，合成 API 領域在 2024 年佔據了市場主導地位，收益佔有率最大，為 70.66%。
  • 預計北美將在 2024 年佔據最大的收益佔有率，為 38.26%，並在預測期內保持領先地位。這是由於癌症以及其他文明病的流行病學不斷上升，從而促進了研發活動，並進而推動了市場成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 活性藥物成分市場：市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
  • 市場動態
  • 市場促進因素
  • 市場限制因素分析
  • 商業環境分析

第 4 章 活性藥物成分市場：按合成類型進行的估計和趨勢分析

  • 細分儀表板
  • 活性藥物成分市場：合成類型變異分析
  • 活性藥物成分市場展望（按合成類型）
  • 2018-2030 年市場規模、預測及趨勢分析
  • 生物API
    • 生物 API 市場，2018-2030 年
  • 組合 API
    • 合成 API 市場，2018 至 2030 年

第 5 章：按製造商類型分類的活性藥物成分市場、估計和趨勢分析

  • 細分儀表板
  • 活性藥物成分市場：製造商類型變化分析
  • 原料藥市場依製造商類型展望
  • 2018-2030 年市場規模、預測及趨勢分析
  • 專屬式API
    • 專屬式API 市場，2018 年至 2030 年
  • 商家 API
    • 商家 API 市場，2018 至 2030 年

第6章：活性藥物成分市場類型、估計與趨勢分析

  • 細分儀表板
  • 活性藥物成分市場：類型變化分析
  • 活性藥物成分市場按類型展望
  • 2018-2030 年市場規模、預測及趨勢分析
  • 通用 API
    • 非專利API 市場，2018 年至 2030 年
  • 創新 API
    • 創新 API 市場，2018-2030 年

第 7 章：活性藥物成分市場：按應用分類的估計和趨勢分析

  • 細分儀表板
  • 活性藥物成分市場：應用趨勢分析
  • 活性藥物成分市場應用前景
  • 2018-2030 年市場規模、預測及趨勢分析
  • 心血管疾病
    • 心血管疾病市場，2018-2030
  • 腫瘤學
    • 腫瘤學市場 2018-2030
  • 中樞神經系統和神經病學
    • 中樞神經系統和神經病學市場 2018-2030
  • 整形外科
    • 2018-2030 年整形外科市場
  • 內分泌學
    • 內分泌市場，2018-2030
  • 呼吸系統醫療設備
    • 呼吸系統醫療設備市場，2018 - 2030 年
  • 胃腸病學
    • 胃腸病學市場，2018-2030 年
  • 腎臟疾病
    • 腎臟疾病市場，2018-2030 年
  • 眼科
    • 2018-2030 年眼科市場
  • 其他
    • 其他市場，2018-2030

第 8 章：按藥物類型分類的活性藥物成分市場、估計和趨勢分析

  • 細分儀表板
  • 活性藥物成分市場：藥物類型變化分析
  • 按藥物類型分類的原料藥市場展望
  • 2018-2030 年市場規模、預測及趨勢分析
  • 處方箋
    • 處方藥市場，2018-2030 年
  • 非處方藥
    • 非處方藥市場，2018-2030 年

第 9 章：按地區分類的活性藥物成分市場、估計和趨勢分析

  • 區域控制面板
  • 2018-2030 年市場規模及預測趨勢分析
  • 北美洲
    • 2018 至 2030 年北美活性藥物成分市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018 至 2030 年歐洲活性藥物成分市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018 年至 2030 年亞太地區活性藥物成分市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018 年至 2030 年拉丁美洲活性藥物成分市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018 年至 2030 年中東和非洲活性藥物成分市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 參與企業概況
  • 參與企業
    • 市場領導者
    • 2024 年活性藥物成分市場佔有率分析
    • 公司簡介
Product Code: GVR-1-68038-348-5

Active Pharmaceutical Ingredients Market Growth & Trends:

The global active pharmaceutical ingredients market size is anticipated to reach USD 359.45 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.85% from 2025 to 2030. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical Ingredients (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in-house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The active pharmaceutical Ingredients market was positively influenced by the COVID-19 pandemic, as countries and significant players produce large quantities of components to meet the demand for the treatment of COVID-19. As a result of the outbreak, drug companies have changed the companies' strategies to focus on a larger patient population. To treat coronavirus, the U.S., for example, requested that HCQ be imported from India. The virus has also impacted Canada's medicine supply system, potentially causing complications for patients. The increasing importance of generics, rise in consumption of biopharmaceuticals, and expanding drug research and development activities for drug manufacturing are the primary drivers driving the growth of the market. However, the market's expansion is likely to be hampered by unfavorable drug price control regimes in several countries and high manufacturing costs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, India has quality raw materials and products, a large workforce, a vast distribution network, and government subsidies through the "Make in India" program.

To address unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In November 2021, Merck & Co Inc. announced that it has acquired Acceleron Pharma, this acquisition would help Merck & Co to expand their cardiovascular portfolio and pipeline.

Active Pharmaceutical Ingredients Market Report Highlights:

  • Innovative APIs held the largest share of 62.0% in 2024, owing to increasing research and development activities for novel drug development and positive government initiatives
  • Captive APIs segment held the largest market share of 51.03% in 2024
  • The synthetic API segment dominated the market with the largest revenue share of 70.66% in 2024, owing to the higher availability of raw materials and easier protocols for the synthesis of these molecules
  • North America accounted for the largest revenue share of 38.26% in 2024 and is expected to maintain its lead over the forecast period. This is attributed to the rising epidemiology of cancer, along with other lifestyle-induced diseases, thus encouraging the R&D activities, thereby boosting the market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Active Pharmaceutical Ingredients Market: Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Increasing geriatric population
    • 3.4.2. Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
    • 3.4.3. Increasing preference for targeted therapy approach in cancer treatment
    • 3.4.4. Increasing preference for outsourcing APIs
  • 3.5. Market Restraint Analysis
    • 3.5.1. High capital investments and production cost
    • 3.5.2. Stringent Safety and handling regulations regarding APIs
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Active Pharmaceutical Ingredients Market: Type of Synthesis Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Active Pharmaceutical Ingredients Market: Type of Synthesis Movement Analysis
  • 4.3. Active Pharmaceutical Ingredients Market by Type of Synthesis Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Biotic APIs
    • 4.5.1. Biotic APIs Market, 2018 - 2030 (USD Billion)
      • 4.5.1.1. Biotech APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
      • 4.5.1.2. Generic APIs
        • 4.5.1.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
      • 4.5.1.3. Innovative APIs
        • 4.5.1.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)
      • 4.5.1.4. Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)
      • 4.5.1.5. Monoclonal Antibodies
        • 4.5.1.5.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Billion)
      • 4.5.1.6. Hormones
        • 4.5.1.6.1. Hormones Market, 2018 - 2030 (USD Billion)
      • 4.5.1.7. Cytokines
        • 4.5.1.7.1. Cytokines Market, 2018 - 2030 (USD Billion)
      • 4.5.1.8. Recombinant Proteins
        • 4.5.1.8.1. Recombinant Proteins Market, 2018 - 2030 (USD Billion)
      • 4.5.1.9. Therapeutic Enzymes
        • 4.5.1.9.1. Therapeutic Enzymes Market, 2018 - 2030 (USD Billion)
      • 4.5.1.10. Vaccines
        • 4.5.1.10.1. Vaccines Market, 2018 - 2030 (USD Billion)
      • 4.5.1.11. Blood Factors
        • 4.5.1.11.1. Blood Factors Market, 2018 - 2030 (USD Billion)
  • 4.6. Synthetic APIs
    • 4.6.1. Synthetic APIs Market, 2018 - 2030 (USD Billion)
      • 4.6.1.1. Synthetic APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
      • 4.6.1.2. Generic APIs
        • 4.6.1.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
      • 4.6.1.3. Innovative APIs
        • 4.6.1.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)

Chapter 5. Active Pharmaceutical Ingredients Market: Type of Manufacturer Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Active Pharmaceutical Ingredients Market: Type Movement Analysis
  • 5.3. Active Pharmaceutical Ingredients Market by Type Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Captive APIs
    • 5.5.1. Captive APIs Market, 2018 - 2030 (USD Billion)
  • 5.6. Merchant APIs
    • 5.6.1. Merchant APIs Market, 2018 - 2030 (USD Billion)

Chapter 6. Active Pharmaceutical Ingredients Market: Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Active Pharmaceutical Ingredients Market: Type Movement Analysis
  • 6.3. Active Pharmaceutical Ingredients Market by Type Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Generic APIs
    • 6.5.1. Generic APIs Market, 2018 - 2030 (USD Billion)
  • 6.6. Innovative APIs
    • 6.6.1. Innovative APIs Market, 2018 - 2030 (USD Billion)

Chapter 7. Active Pharmaceutical Ingredients Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Active Pharmaceutical Ingredients Market: Application Movement Analysis
  • 7.3. Active Pharmaceutical Ingredients Market by Application Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Cardiovascular Diseases
    • 7.5.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Billion)
  • 7.6. Oncology
    • 7.6.1. Innovative APIs Oncology Market, 2018 - 2030 (USD Billion)
  • 7.7. CNS and Neurology
    • 7.7.1. CNS and Neurology Market, 2018 - 2030 (USD Billion)
  • 7.8. Orthopedic
    • 7.8.1. Orthopedic Market, 2018 - 2030 (USD Billion)
  • 7.9. Endocrinology
    • 7.9.1. Endocrinology Market, 2018 - 2030 (USD Billion)
  • 7.10. Pulmonology
    • 7.10.1. Pulmonology Market, 2018 - 2030 (USD Billion)
  • 7.11. Gastroenterology
    • 7.11.1. Gastroenterology Market, 2018 - 2030 (USD Billion)
  • 7.12. Nephrology
    • 7.12.1. Nephrology Market, 2018 - 2030 (USD Billion)
  • 7.13. Ophthalmology
    • 7.13.1. Ophthalmology Market, 2018 - 2030 (USD Billion)
  • 7.14. Others
    • 7.14.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 8. Active Pharmaceutical Ingredients Market: Type of Drug Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Active Pharmaceutical Ingredients Market: Type of Drug Movement Analysis
  • 8.3. Active Pharmaceutical Ingredients Market by Type of Drug Outlook (USD Million)
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5. Prescription
    • 8.5.1. Prescription Market, 2018 - 2030 (USD Billion)
  • 8.6. OTC
    • 8.6.1. OTC Market, 2018 - 2030 (USD Billion)

Chapter 9. Active Pharmaceutical Ingredients Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.3. North America
    • 9.3.1. North America Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Reimbursement Scenario
      • 9.3.2.6. U.S. Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. Canada Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. Mexico Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.4. Europe
    • 9.4.1. Europe Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.2. Germany
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Reimbursement Scenario
      • 9.4.2.6. Germany Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.3. UK
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. UK Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. France Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. Italy Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. Spain Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Denmark Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Target Disease Prevalence
      • 9.4.8.3. Competitive Scenario
      • 9.4.8.4. Regulatory Framework
      • 9.4.8.5. Reimbursement Scenario
      • 9.4.8.6. Sweden Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Target Disease Prevalence
      • 9.4.9.3. Competitive Scenario
      • 9.4.9.4. Regulatory Framework
      • 9.4.9.5. Reimbursement Scenario
      • 9.4.9.6. Norway Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Reimbursement Scenario
      • 9.5.2.6. Japan Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. China Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. India Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.5. South Korea
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Prevalence
      • 9.5.5.3. Competitive Scenario
      • 9.5.5.4. Regulatory Framework
      • 9.5.5.5. Reimbursement Scenario
      • 9.5.5.6. South Korea Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.6. Australia
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Target Disease Prevalence
      • 9.5.6.3. Competitive Scenario
      • 9.5.6.4. Regulatory Framework
      • 9.5.6.5. Reimbursement Scenario
      • 9.5.6.6. Australia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.7. Thailand
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Target Disease Prevalence
      • 9.5.7.3. Competitive Scenario
      • 9.5.7.4. Regulatory Framework
      • 9.5.7.5. Reimbursement Scenario
      • 9.5.7.6. Thailand Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.6. Latin America
    • 9.6.1. Latin America Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Reimbursement Scenario
      • 9.6.2.6. Brazil Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. Argentina Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.7. MEA
    • 9.7.1. MEA Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Target Disease Prevalence
      • 9.7.2.3. Competitive Scenario
      • 9.7.2.4. Regulatory Framework
      • 9.7.2.5. Reimbursement Scenario
      • 9.7.2.6. South Africa Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Target Disease Prevalence
      • 9.7.3.3. Competitive Scenario
      • 9.7.3.4. Regulatory Framework
      • 9.7.3.5. Reimbursement Scenario
      • 9.7.3.6. Saudi Arabia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Target Disease Prevalence
      • 9.7.4.3. Competitive Scenario
      • 9.7.4.4. Regulatory Framework
      • 9.7.4.5. Reimbursement Scenario
      • 9.7.4.6. UAE Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Target Disease Prevalence
      • 9.7.5.3. Competitive Scenario
      • 9.7.5.4. Regulatory Framework
      • 9.7.5.5. Reimbursement Scenario
      • 9.7.5.6. Kuwait Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)

Chapter 10. Competitive Landscape

  • 10.1. Participant's overview
  • 10.2. Financial performance
  • 10.3. Participant categorization
    • 10.3.1. Market Leaders
    • 10.3.2. Active Pharmaceutical Ingredients Market Share Analysis, 2024
    • 10.3.3. Company Profiles
      • 10.3.3.1. Dr. Reddy's Laboratories Ltd.
        • 10.3.3.1.1. Company Overview
        • 10.3.3.1.2. Financial Performance
        • 10.3.3.1.3. Product Benchmarking
        • 10.3.3.1.4. Strategic Initiatives
      • 10.3.3.2. Sun Pharmaceutical Industries Ltd.
        • 10.3.3.2.1. Company Overview
        • 10.3.3.2.2. Financial Performance
        • 10.3.3.2.3. Product Benchmarking
        • 10.3.3.2.4. Strategic Initiatives
      • 10.3.3.3. Teva Pharmaceutical Industries Ltd.
        • 10.3.3.3.1. Company Overview
        • 10.3.3.3.2. Financial Performance
        • 10.3.3.3.3. Product Benchmarking
        • 10.3.3.3.4. Strategic Initiatives
      • 10.3.3.4. Cipla Inc.
        • 10.3.3.4.1. Company Overview
        • 10.3.3.4.2. Financial Performance
        • 10.3.3.4.3. Product Benchmarking
        • 10.3.3.4.4. Strategic Initiatives
      • 10.3.3.5. AbbVie Inc.
        • 10.3.3.5.1. Company Overview
        • 10.3.3.5.2. Financial Performance
        • 10.3.3.5.3. Product Benchmarking
        • 10.3.3.5.4. Strategic Initiatives
      • 10.3.3.6. Aurobindo Pharma
        • 10.3.3.6.1. Company Overview
        • 10.3.3.6.2. Financial Performance
        • 10.3.3.6.3. Product Benchmarking
        • 10.3.3.6.4. Strategic Initiatives
      • 10.3.3.7. Sandoz International GmbH (Novartis AG)
        • 10.3.3.7.1. Company Overview
        • 10.3.3.7.2. Financial Performance
        • 10.3.3.7.3. Product Benchmarking
        • 10.3.3.7.4. Strategic Initiatives
      • 10.3.3.8. Viatris Inc.
        • 10.3.3.8.1. Company Overview
        • 10.3.3.8.2. Financial Performance
        • 10.3.3.8.3. Product Benchmarking
        • 10.3.3.8.4. Strategic Initiatives
      • 10.3.3.9. Fresenius Kabi AG
        • 10.3.3.9.1. Company Overview
        • 10.3.3.9.2. Financial Performance
        • 10.3.3.9.3. Product Benchmarking
        • 10.3.3.9.4. Strategic Initiatives
      • 10.3.3.10. STADA Arzneimittel AG
        • 10.3.3.10.1. Company Overview
        • 10.3.3.10.2. Financial Performance
        • 10.3.3.10.3. Product Benchmarking
        • 10.3.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 Global Active Pharmaceutical Ingredients Market, By Region, 2018 - 2030 (USD Billion)
  • Table 2 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 3 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 4 Global Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 5 Global Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 6 Global Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 7 North America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 8 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 9 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 10 North America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 11 North America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 12 North America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 13 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 14 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 15 U.S. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 16 U.S. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 17 U.S. Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 18 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 19 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 20 Canada Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 21 Canada Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 22 Canada Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 23 Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 24 Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 25 Mexico Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 26 Mexico Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 27 Mexico Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 28 Europe Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 29 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 30 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 31 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 32 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 33 Europe Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 34 UK Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 35 UK Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 36 UK Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 37 UK Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 38 UK Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 39 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 40 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 41 Germany Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 42 Germany Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 43 Germany Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 44 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 45 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 46 France Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 47 France Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 48 France Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 49 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 50 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 51 Italy Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 52 Italy Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 53 Italy Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 54 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 55 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 56 Spain Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 57 Spain Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 58 Spain Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 59 Denmark Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 60 Denmark Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 61 Denmark Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 62 Denmark Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 63 Denmark Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 64 Sweden Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 65 Sweden Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 66 Sweden Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 67 Sweden Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 68 Sweden Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 69 Norway Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 70 Norway Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 71 Norway Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 72 Norway Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 73 Norway Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 74 Asia Pacific Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 75 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 76 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 77 Asia Pacific Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 78 Asia Pacific Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 79 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 80 Japan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 81 Japan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 82 Japan Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 83 Japan Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 84 Japan Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 85 China Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 86 China Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 87 China Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 88 China Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 89 China Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 90 India Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 91 India Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 92 India Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 93 India Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 94 India Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 95 Australia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 96 Australia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 97 Australia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 98 Australia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 99 Australia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 100 South Korea Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 101 South Korea Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 102 South Korea Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 103 South Korea Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 104 South Korea Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 105 Thailand Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 106 Thailand Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 107 Thailand Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 108 Thailand Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 109 Thailand Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 110 Latin America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 111 Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 112 Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 113 Latin America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 114 Latin America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 115 Latin America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 116 Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 117 Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 118 Brazil Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 119 Brazil Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 120 Brazil Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 121 Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 122 Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 123 Argentina Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 124 Argentina Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 125 Argentina Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 126 Middle East & Africa Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 127 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 128 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 129 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 130 Middle East & Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 131 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 132 South Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 133 South Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 134 South Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 135 South Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 136 South Africa Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 137 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 138 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 139 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 140 Saudi Arabia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 141 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 142 UAE Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 143 UAE Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 144 UAE Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 145 UAE Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 146 UAE Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 147 Kuwait Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 148 Kuwait Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 149 Kuwait Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 150 Kuwait Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 151 Kuwait Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 API Market market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Active pharmaceutical ingredients market: Type of synthesis movement analysis
  • Fig. 12 Biotech APIs market, 2018 - 2030 (USD Billion)
  • Fig. 13 Synthetic APIs market, 2018 - 2030 (USD Billion)
  • Fig. 14 Active pharmaceutical ingredients market: Type of manufacturer movement analysis
  • Fig. 15 Captive APIs market, 2018 - 2030 (USD Billion)
  • Fig. 16 Merchant APIs market, 2018 - 2030 (USD Billion)
  • Fig. 17 Active pharmaceutical ingredients market: Type movement analysis
  • Fig. 18 Generic APIs market, 2018 - 2030 (USD Billion)
  • Fig. 19 Innovative APIs market, 2018 - 2030 (USD Billion)
  • Fig. 20 Active pharmaceutical ingredients market: Application movement analysis
  • Fig. 21 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
  • Fig. 22 Oncology market, 2018 - 2030 (USD Billion)
  • Fig. 23 CNS and Neurology market, 2018 - 2030 (USD Billion)
  • Fig. 24 Orthopaedic market, 2018 - 2030 (USD Billion)
  • Fig. 25 Endocrinology market, 2018 - 2030 (USD Billion)
  • Fig. 26 Pulmonology market, 2018 - 2030 (USD Billion)
  • Fig. 27 Gastroenterology market, 2018 - 2030 (USD Billion)
  • Fig. 28 Nephrology market, 2018 - 2030 (USD Billion)
  • Fig. 29 Ophthalmology market, 2018 - 2030 (USD Billion)
  • Fig. 30 Others market, 2018 - 2030 (USD Billion)
  • Fig. 31 Active pharmaceutical ingredients market: Type of drug movement analysis
  • Fig. 32 Prescription market, 2018 - 2030 (USD Billion)
  • Fig. 33 OTC market, 2018 - 2030 (USD Billion)
  • Fig. 34 North America active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 35 U.S. active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 36 Canada active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 37 Mexico active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 38 Europe active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 39 UK active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 40 Germany active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 41 Italy active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 42 Spain active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 43 France active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 44 Denmark active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 45 Sweden active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 46 Norway active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 47 Asia Pacific active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 48 Japan active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 49 China active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 50 India active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 51 Australia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 52 Thailand active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 53 South Korea active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 54 Thailand active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 55 Latin America active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 56 Brazil active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 57 Argentina active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 58 MEA active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 59 South Africa active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 60 Saudi Arabia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 61 UAE active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 62 Kuwait active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)